Quest Diagnostics Inc (DGX) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 10.00M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 5.63B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 16.94B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $10.00M | $5.63B | (m) | (m) | $16.94B | (m) |
| 2026-03-31 | (m) | (m) | $503.00M | (m) | (m) | (m) | $16.67B | (m) |
| 2025-12-31 | (m) | (m) | $504.00M | $5.17B | (m) | (m) | $16.23B | (m) |
| 2025-09-30 | (m) | (m) | $504.00M | (m) | (m) | (m) | $16.20B | (m) |
| 2025-06-30 | (m) | (m) | $504.00M | (m) | (m) | (m) | $15.97B | (m) |
| 2025-03-31 | (m) | (m) | $1.00M | (m) | (m) | (m) | $15.80B | (m) |
| 2024-12-31 | (m) | (m) | $602.00M | $5.62B | (m) | (m) | $16.15B | (m) |
| 2024-09-30 | (m) | (m) | $603.00M | $5.65B | (m) | (m) | $16.09B | (m) |
| 2024-06-30 | (m) | (m) | $606.00M | (m) | (m) | (m) | $13.88B | (m) |
| 2024-03-31 | (m) | (m) | $906.00M | (m) | (m) | (m) | $13.95B | (m) |
| 2023-12-31 | (m) | (m) | $303.00M | $4.41B | (m) | (m) | $14.02B | (m) |
| 2023-09-30 | (m) | (m) | $304.00M | (m) | (m) | (m) | $13.48B | (m) |
| 2023-06-30 | (m) | (m) | $518.00M | (m) | (m) | (m) | $13.43B | (m) |
| 2023-03-31 | (m) | (m) | $2.00M | (m) | (m) | (m) | $12.79B | (m) |
| 2022-12-31 | (m) | (m) | $2.00M | $3.98B | (m) | (m) | $12.84B | (m) |
| 2022-09-30 | (m) | (m) | $2.00M | (m) | (m) | (m) | $13.22B | (m) |
| 2022-06-30 | (m) | (m) | $2.00M | (m) | (m) | (m) | $13.31B | (m) |
| 2022-03-31 | (m) | (m) | $2.00M | (m) | (m) | (m) | $13.44B | (m) |
| 2021-12-31 | (m) | (m) | $2.00M | $4.01B | (m) | (m) | $13.61B | (m) |
| 2021-09-30 | (m) | (m) | $1.00M | (m) | (m) | (m) | $13.57B | (m) |
| 2021-06-30 | (m) | (m) | $2.00M | (m) | (m) | (m) | $12.86B | (m) |
| 2021-03-31 | (m) | (m) | $2.00M | (m) | (m) | (m) | $13.93B | (m) |
| 2020-12-31 | (m) | (m) | $2.00M | $4.01B | (m) | (m) | $14.03B | (m) |
| 2020-09-30 | (m) | (m) | $555.00M | $4.02B | (m) | (m) | $14.14B | (m) |
| 2020-06-30 | (m) | (m) | $555.00M | $4.02B | (m) | (m) | $12.99B | (m) |
| 2020-03-31 | (m) | (m) | $3.00M | $4.03B | (m) | (m) | $12.05B | (m) |
| 2019-12-31 | (m) | (m) | $804.00M | $3.97B | (m) | (m) | $12.84B | (m) |
| 2019-09-30 | (m) | (m) | $805.00M | $3.19B | (m) | (m) | $12.02B | (m) |
| 2019-06-30 | (m) | (m) | $807.00M | $3.17B | (m) | (m) | $11.76B | (m) |
| 2019-03-31 | (m) | (m) | $1.11B | $3.13B | (m) | (m) | $11.94B | (m) |
| 2018-12-31 | (m) | (m) | $464.00M | $3.43B | (m) | (m) | $11.00B | (m) |
| 2017-12-31 | (m) | (m) | $36.00M | $3.75B | (m) | (m) | $10.50B | (m) |
| 2016-12-31 | (m) | (m) | $6.00M | $3.73B | (m) | (m) | $10.10B | (m) |
| 2016-09-30 | (m) | (m) | $7.00M | $3.81B | (m) | (m) | $10.17B | (m) |
| 2016-06-30 | (m) | (m) | $7.00M | $3.83B | (m) | (m) | $10.11B | (m) |
| 2016-03-31 | (m) | (m) | $158.00M | $3.74B | (m) | (m) | $10.10B | (m) |
| 2015-12-31 | (m) | (m) | $159.00M | $3.49B | (m) | (m) | $9.96B | (m) |
| 2015-09-30 | (m) | (m) | $160.00M | $3.57B | (m) | (m) | $10.07B | (m) |
| 2015-06-30 | (m) | (m) | $168.00M | $3.57B | (m) | (m) | $9.72B | (m) |
| 2015-03-31 | (m) | (m) | $1.04B | $3.69B | (m) | (m) | $10.61B | (m) |
| 2014-12-31 | (m) | (m) | $518.00M | $3.24B | (m) | (m) | $9.88B | (m) |
| 2014-09-30 | (m) | (m) | $22.00M | $3.73B | (m) | (m) | $9.80B | (m) |
| 2014-06-30 | (m) | (m) | $25.00M | $3.74B | (m) | (m) | $9.76B | (m) |
| 2014-03-31 | (m) | (m) | $28.00M | $3.72B | (m) | (m) | $9.55B | (m) |
| 2013-12-31 | (m) | (m) | $212.00M | (m) | (m) | (m) | $8.95B | (m) |
| 2012-12-31 | (m) | (m) | $9.40M | (m) | (m) | (m) | $9.28B | (m) |
| 2011-12-31 | (m) | (m) | $569.39M | (m) | (m) | (m) | $9.31B | (m) |
| 2011-09-30 | (m) | (m) | $750.91M | (m) | (m) | (m) | $9.33B | (m) |
| 2011-06-30 | (m) | (m) | $909.67M | (m) | (m) | (m) | $9.43B | (m) |
| 2011-03-31 | (m) | (m) | $629.24M | (m) | (m) | (m) | $9.22B | (m) |
| 2010-12-31 | (m) | (m) | $349.00M | $2.64B | (m) | (m) | $8.53B | (m) |
| 2010-09-30 | (m) | (m) | $331.53M | (m) | (m) | (m) | $8.46B | (m) |
| 2010-06-30 | (m) | (m) | $171.13M | (m) | (m) | (m) | $8.48B | (m) |
| 2010-03-31 | (m) | (m) | $170.40M | (m) | (m) | (m) | $8.52B | (m) |
| 2009-12-31 | (m) | (m) | $170.51M | (m) | (m) | (m) | $8.56B | (m) |
| 2008-12-31 | (m) | (m) | $5.14M | (m) | (m) | (m) | $8.40B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |